I 

113TH CONGRESS 

2D SESSION H. R. 5845 

To authorize the Attorney General to award grants to address the national 

epidemics of prescription opioid abuse and heroin use. 

IN THE HOUSE OF REPRESENTATIVES 

DECEMBER 10, 2014 

Mr. SENSENBRENNER (for himself, Mr. SCOTT of Virginia, Mr. RYAN of Ohio, 

Ms. BASS, Mr. MARINO, and Mr. JOYCE) introduced the following bill; 

which was referred to the Committee on the Judiciary, and in addition 

to the Committees on Energy and Commerce and Education and the 

Workforce, for a period to be subsequently determined by the Speaker, 

in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To authorize the Attorney General to award grants to address the national epidemics of prescription opioid abuse 

and heroin use. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 

4 (a) SHORT TITLE.—This Act may be cited as the 

5 ‘‘Comprehensive Addiction and Recovery Act of 2014’’. 

6 (b) TABLE OF CONTENTS.—The table of contents for 

7 this Act is as follows: 

mstockstill on DSK4VPTVN1PROD with BILLS

2 

•HR 5845 IH

Sec. 1. Short title; table of contents. 

Sec. 2. Findings. 

Sec. 3. Definitions. 

TITLE I—PREVENTION AND EDUCATION 

Sec. 101. Development of best prescribing practices. 

Sec. 102. National education campaign. 

Sec. 103. Community-based coalition enhancement grants to address local drug 

crises. 

TITLE II—LAW ENFORCEMENT AND TREATMENT 

Sec. 201. Treatment alternative to incarceration programs. 

Sec. 202. Law enforcement naloxone training and implementation pilot. 

Sec. 203. Prescription drug take back expansion. 

TITLE III—TREATMENT AND RECOVERY 

Sec. 301. Evidence-based opioid and heroin treatment and interventions demonstration. 

Sec. 302. Criminal justice medication assisted treatment and interventions demonstration. 

Sec. 303. National youth recovery initiative. 

Sec. 304. Building communities of recovery. 

TITLE IV—ADDRESSING COLLATERAL CONSEQUENCES 

Sec. 401. Correctional education demonstration grant program. 

Sec. 402. Revision of FAFSA form. 

Sec. 403. National task force on recovery and collateral consequences. 

TITLE V—ADDICTION AND TREATMENT SERVICES FOR WOMEN, 

FAMILIES, AND VETERANS 

Sec. 501. Authority to award competitive grants to address opioid and heroin 

abuse by pregnant and parenting female offenders. 

Sec. 502. Grants for family-based substance abuse treatment. 

Sec. 503. Veterans’ treatment courts. 

TITLE VI—INCENTIVIZING STATE COMPREHENSIVE INITIATIVES 

TO ADDRESS OPIOID AND HEROIN ABUSE 

Sec. 601. State demonstration grants for comprehensive opioid abuse response. 

TITLE VII—OFFSET 

Sec. 701. Offset. 

1 SEC. 2. FINDINGS. 

2 Congress finds the following: 

3 (1) The abuse of heroin and prescription pain4 killers is having a devastating effect on public health 

5 and safety in communities across the United States. 

mstockstill on DSK4VPTVN1PROD with BILLS

3 

•HR 5845 IH

1 According to the Centers for Disease Control and 

2 Prevention, drug overdose deaths now surpass traffic 

3 crashes in the number of deaths caused by injury in 

4 the United States. In 2011, an average of about 110 

5 people in the United States died from drug overdose 

6 every day. 

7 (2) Law enforcement officials and treatment ex8 perts throughout the country report that many pre9 scription opioid users have turned to heroin as a 

10 cheaper or more easily obtained alternative to pre11 scription drugs. 

12 (3) Opioid pain relievers are the most widely 

13 misused or abused controlled prescription drugs 

14 (commonly referred to as ‘‘CPDs’’) and are involved 

15 in most CPD-related overdose incidents. According 

16 to the Drug Abuse Warning Network (commonly 

17 known as ‘‘DAWN’’), the estimated number of emer18 gency department visits involving nonmedical use of 

19 prescription opiates or opioids increased by 112 per20 cent, from 84,671 to 179,787, between 2006 and 

21 2010. 

22 (4) According to a report by the National Asso23 ciation of State Alcohol and Drug Abuse Directors 

24 (commonly referred to as ‘‘NASADAD’’), 37 States 

25 reported an increase in admissions to treatment for 

mstockstill on DSK4VPTVN1PROD with BILLS

4 

•HR 5845 IH

1 heroin use during the past 2 years, while admissions 

2 to treatment for prescription opiates increased 500 

3 percent from 2000 to 2012. 

4 (5) Addiction is a treatable disease. Discoveries 

5 in the science of addiction have led to advances in 

6 the treatment of substance use disorders that help 

7 people stop abusing drugs and prescription medica8 tions and resume their productive lives. 

9 (6) According to the Office of National Drug 

10 Control Policy (commonly referred to as 

11 ‘‘ONDCP’’), approximately 22,700,000 people in the 

12 United States needed substance use disorder treat13 ment in 2013, but only 2,500,000 people received it. 

14 (7) Effective substance abuse prevention can 

15 yield major economic dividends. Every dollar in16 vested in prevention can lead to savings between $2 

17 and $20. 

18 (8) According to the National Institute on Drug 

19 Abuse, when schools and communities properly im20 plement science-validated substance abuse prevention 

21 programs, alcohol, tobacco, and illicit drug abuse are 

22 reduced. Such programs help teachers, parents, and 

23 health care professionals shape the perceptions of 

24 youths about the risks of drug abuse. 

mstockstill on DSK4VPTVN1PROD with BILLS

5 

•HR 5845 IH

1 (9) Diverting individuals with substance use 

2 disorders from criminal justice systems into commu3 nity-based treatment can save billions of dollars and 

4 prevent sizeable numbers of crimes, arrests, and re5 incarcerations over the course of those individuals’ 

6 lives. 

7 (10) According to the Drug Enforcement Agen8 cy, more than 1,700 tons of expired, unwanted pre9 scription medications have been collected over the 

past 31 10 ⁄2 years, following the enactment of the Se11 cure and Responsible Drug Disposal Act of 2010 

12 (Public Law 111–273; 124 Stat. 2858). 

13 (11) Research shows that combining treatment 

14 medications with behavioral therapy is the best way 

15 to ensure success for most patients. Treatment ap16 proaches must be tailored to address the drug abuse 

17 patterns and drug-related medical, psychiatric, and 

18 social problems of each individual. Different types of 

19 medications may be useful at different stages of 

20 treatment to help a patient stop abusing drugs, stay 

21 in treatment, and avoid relapse. 

22 (12) Research indicates that combating the epi23 demic of opioid abuse, including abuse of prescrip24 tion painkillers and, increasingly, heroin, requires a 

25 multi-pronged approach that involves reducing drug 

mstockstill on DSK4VPTVN1PROD with BILLS

6 

•HR 5845 IH

1 diversion, expanding delivery of existing treatments 

2 (including medication-assisted treatments), expand3 ing access to overdose medications and interventions, 

4 and the development of new medications for pain 

5 that can augment the existing treatment arsenal. 

6 SEC. 3. DEFINITIONS. 

7 In this Act— 

8 (1) the term ‘‘Indian tribe’’ has the meaning 

9 given the term in section 4 of the Indian Self-Deter10 mination and Education Assistance Act (25 U.S.C. 

11 450b); 

12 (2) the term ‘‘medication-assisted treatment’’ 

13 means the use, for problems relating to heroin and 

14 other opioids, of medications approved by the Food 

15 and Drug Administration in combination with coun16 seling and behavioral therapies; 

17 (3) the term ‘‘ONDCP Recovery Branch’’ 

18 means the Recovery Branch of the Office of Na19 tional Drug Control Policy; 

20 (4) the term ‘‘opioid’’ means any drug having 

21 an addiction-forming or addiction-sustaining liability 

22 similar to morphine or being capable of conversion 

23 into a drug having such addiction-forming or addic24 tion-sustaining liability; 

mstockstill on DSK4VPTVN1PROD with BILLS

7 

•HR 5845 IH

1 (5) the term ‘‘Single State Authority for Sub2 stance Abuse’’ has the meaning given the term in 

3 section 201(e) of the Second Chance Act of 2007 

4 (42 U.S.C. 17521(e)); and 

5 (6) the term ‘‘State’’ means any State of the 

6 United States, the District of Columbia, the Com7 monwealth of Puerto Rico, and any territory or pos8 session of the United States. 

9 TITLE I—PREVENTION AND 

10 EDUCATION 

11 SEC. 101. DEVELOPMENT OF BEST PRESCRIBING PRAC12 TICES. 

13 (a) INTERAGENCY TASK FORCE.—Not later than 120 

14 days after the date of enactment of this Act, the Secretary 

15 of Health and Human Services (referred to in this section 

16 as the ‘‘Secretary’’), in cooperation with the Secretary of 

17 Veterans Affairs, the Secretary of Defense, and the Ad18 ministrator of the Drug Enforcement Administration, 

19 shall convene a Pain Management Best Practices Inter20 agency Task Force (referred to in this section as the ‘‘task 

21 force’’). 

22 (b) MEMBERSHIP.—The task force shall be com23 prised of— 

24 (1) representatives of— 

mstockstill on DSK4VPTVN1PROD with BILLS

8 

•HR 5845 IH

1 (A) the Department of Health and Human 

2 Services; 

3 (B) the Department of Veterans Affairs; 

4 (C) the Department of Defense; 

5 (D) the Drug Enforcement Administration; 

6 (E) the Centers for Disease Control and 

7 Prevention; 

8 (F) the Institute of Medicine; and 

9 (G) the Office of National Drug Control 

10 Policy; 

11 (2) the Director of the National Institutes of 

12 Health; 

13 (3) physicians, dentists, and nonphysician pre14 scribers; 

15 (4) pharmacists; 

16 (5) experts in the fields of pain research and 

17 addiction research; 

18 (6) representatives of— 

19 (A) pain management professional organi20 zations; 

21 (B) the mental health treatment commu22 nity; 

23 (C) the addiction treatment community; 

24 (D) pain advocacy groups; and 

mstockstill on DSK4VPTVN1PROD with BILLS

9 

•HR 5845 IH

1 (E) groups with expertise around overdose 

2 reversal; and 

3 (7) other stakeholders, as the Secretary deter4 mines appropriate. 

5 (c) DUTIES.—The task force shall— 

6 (1) not later than 180 days after the date on 

7 which the task force is convened under subsection 

8 (a), develop best practices for pain management and 

9 prescribing pain medication, taking into consider10 ation— 

11 (A) existing pain management research; 

12 (B) recommendations from relevant con13 ferences; and 

14 (C) ongoing efforts at the State and local 

15 levels and by medical professional organizations 

16 to develop improved pain management strate17 gies; 

18 (2) solicit and take into consideration public 

19 comment on the practices developed under para20 graph (1), amending such best practices if appro21 priate; and 

22 (3) develop a strategy for disseminating infor23 mation about the best practices developed under 

24 paragraphs (1) and (2) to prescribers, pharmacists, 

mstockstill on DSK4VPTVN1PROD with BILLS

10 

•HR 5845 IH

1 State medical boards, and other parties, as the Sec2 retary determines appropriate. 

3 (d) LIMITATION.—The task force shall not have rule4 making authority. 

5 (e) REPORT.—Not later than 270 days after the date 

6 on which the task force is convened under subsection (a), 

7 the task force shall submit to Congress a report that in8 cludes— 

9 (1) the strategy for disseminating best practices 

10 developed under subsection (c); 

11 (2) the results of a feasibility study on linking 

12 best practices developed under subsection (c) to re13 ceiving and renewing registrations under section 

14 303(f) of the Controlled Substances Act (21 U.S.C. 

15 823(f)); and 

16 (3) recommendations on how to apply best 

17 practices developed under subsection (c) to improve 

18 prescribing practices at medical facilities, including 

19 medical facilities of the Veterans Health Administra20 tion. 

21 SEC. 102. NATIONAL EDUCATION CAMPAIGN. 

22 (a) DEFINITION.—In this section, the term ‘‘eligible 

23 entity’’ means a State, unit of local government, or non24 profit organization. 

mstockstill on DSK4VPTVN1PROD with BILLS

11 

•HR 5845 IH

1 (b) PROGRAM AUTHORIZED.—Section 1177 of chap2 ter 16 of Drug Abuse Prevention, Treatment and Reha3 bilitation (21 U.S.C. chapter 16 subchapter IV) is amend4 ed— 

5 (1) by adding subsection 1177b and inserting 

6 the following: 

7 ‘‘The Attorney General, in coordination with the Sec8 retary of Health and Human Services, the Director of the 

9 Office of National Drug Control Policy, the Secretary of 

10 Education, the Administrator of the Substance Abuse and 

11 Mental Health Services Administration, and the Director 

12 of the Centers for Disease Control and Prevention, may 

13 make grants to eligible entities to expand educational ef14 forts to prevent abuse of opioids, heroin, and other sub15 stances of abuse, understand addiction as a chronic dis16 ease, and promote treatment and recovery, including— 

17 ‘‘(1) parent and caretaker-focused prevention 

18 efforts, including— 

19 ‘‘(A) the development of research-based 

20 community education online and social media 

21 materials with an accompanying toolkit that 

22 can be disseminated to communities to educate 

23 parents and other caretakers of teens on— 

24 ‘‘(i) how to educate teens about opioid 

25 and heroin abuse; 

mstockstill on DSK4VPTVN1PROD with BILLS

12 

•HR 5845 IH

1 ‘‘(ii) how to intervene if a parent 

2 thinks or knows their teen is abusing 

3 opioids or heroin; 

4 ‘‘(iii) signs of opioid or heroin over5 dose; and 

6 ‘‘(iv) the use of naloxone to prevent 

7 death from opioid or heroin overdose; 

8 ‘‘(B) the development of detailed digital 

9 and print educational materials to accompany 

10 the online and social media materials and tool11 kit described in subparagraph (A); 

12 ‘‘(C) the development and dissemination of 

13 public service announcements to— 

14 ‘‘(i) raise awareness of heroin and 

15 opioid abuse among parents and other 

16 caretakers; 

17 ‘‘(ii) motivate parents and other care18 takers to visit online educational materials 

19 on heroin and opioid abuse; and 

20 ‘‘(iii) provide information for public 

21 health agencies and nonprofit organiza22 tions that provide overdose reversal and 

23 prevention services and community refer24 rals; and 

mstockstill on DSK4VPTVN1PROD with BILLS

13 

•HR 5845 IH

1 ‘‘(D) the dissemination of educational ma2 terials to the media through— 

3 ‘‘(i) a town hall or panel discussion 

4 with experts; 

5 ‘‘(ii) a press release; 

6 ‘‘(iii) an online news release; 

7 ‘‘(iv) a media tour; and 

8 ‘‘(v) sharable infographics; 

9 ‘‘(2) prevention efforts focused on teenagers, 

10 college students, and college-age individuals, includ11 ing— 

12 ‘‘(A) the development of a national digital 

13 campaign; and 

14 ‘‘(B) the development of a community edu15 cation toolkit for use by community coalitions; 

16 ‘‘(3) campaigns to inform individuals about 

17 available resources to aid in recovery from substance 

18 use disorder; 

19 ‘‘(4) encouragement of individuals in or seeking 

20 recovery from substance use disorder to enter the 

21 health care system; or 

22 ‘‘(5) adult-focused awareness efforts, including 

23 efforts focused on older adults, relating to prescrip24 tion medication disposal, opioid and heroin abuse, 

mstockstill on DSK4VPTVN1PROD with BILLS

14 

•HR 5845 IH

1 signs of overdose, and the use of naloxone for rever2 sal. 

3 ‘‘(c) APPLICATION.— 

4 ‘‘(1) IN GENERAL.—An eligible entity desiring a 

5 grant under this section shall submit an application 

6 to the Attorney General— 

7 ‘‘(A) that meets the criteria under para8 graph (2); and 

9 ‘‘(B) at such time, in such manner, and 

10 accompanied by such information as the Attor11 ney General may require. 

12 ‘‘(2) CRITERIA.—An eligible entity, in submit13 ting an application under paragraph (1), shall— 

14 ‘‘(A) describe the evidence-based method15 ology and outcome measurements that will be 

16 used to evaluate the program funded with a 

17 grant under this section; 

18 ‘‘(B) specifically explain how the measure19 ments described in subparagraph (A) will pro20 vide valid measures of the impact of the pro21 gram described in subparagraph (A); 

22 ‘‘(C) describe how the program described 

23 in subparagraph (A) could be broadly replicated 

24 if demonstrated to be effective; 

mstockstill on DSK4VPTVN1PROD with BILLS

15 

•HR 5845 IH

1 ‘‘(D) demonstrate that all planned services 

2 will be research-informed, which may include 

3 evidence-based practices documented in— 

4 ‘‘(i) the report of the Institute of 

5 Medicine entitled ‘Preventing Mental, 

6 Emotional, and Behavioral Disorders 

7 Among Young People’; or 

8 ‘‘(ii) the National Registry of Effec9 tive Programs and Practices (commonly re10 ferred to as ‘NREPP’ of the Substance 

11 Abuse and Mental Health Administration); 

12 and 

13 ‘‘(E) demonstrate that the eligible entity 

14 will effectively integrate and sustain the pro15 gram described in subparagraph (A) into cur16 riculum or community outreach efforts. 

17 ‘‘(d) USE OF FUNDS.—A grantee shall use a grant 

18 received under this section for expenses of educational ef19 forts to— 

20 ‘‘(1) prevent abuse of opioids, heroin, alcohol, 

21 and other drugs; or 

22 ‘‘(2) promote treatment and recovery. 

23 ‘‘(e) DURATION.—The Attorney General shall award 

24 grants under this section for a period not to exceed 2 

25 years. 

mstockstill on DSK4VPTVN1PROD with BILLS

16 

•HR 5845 IH

1 ‘‘(f) INFORMATION SHARING.—The Office of the At2 torney General, in coordination with the Substance Abuse 

3 and Mental Health Services Administration and the De4 partment of Education, shall review existing evidence5 based programs and emerging practices and programs and 

6 provide information to schools and communities about 

7 such programs and practices. 

8 ‘‘(g) AUTHORIZATION OF APPROPRIATIONS.—There 

9 are authorized to be appropriated to carry out this section 

10 $2,500,000 for each of fiscal years 2016 through 2020.’’. 

11 SEC. 103. COMMUNITY-BASED COALITION ENHANCEMENT 

12 GRANTS TO ADDRESS LOCAL DRUG CRISES. 

13 (a) DEFINITIONS.—In this section— 

14 (1) the term ‘‘Drug-Free Communities Act of 

15 1997’’ means chapter 2 of subtitle A of title I of the 

16 Anti-Drug Abuse Act of 1988 (21 U.S.C. 1521 et 

17 seq.); 

18 (2) the term ‘‘eligible entity’’ means an organi19 zation that— 

20 (A) on or before the date of submitting an 

21 application for a grant under this section, re22 ceives or has received a grant under the Drug23 Free Communities Act of 1997; and 

24 (B) has documented, using local data, 

25 rates of abuse of opioids at levels that are— 

mstockstill on DSK4VPTVN1PROD with BILLS

17 

•HR 5845 IH

1 (i) significantly higher than the na2 tional average as determined by the Attor3 ney General (including appropriate consid4 eration of the Monitoring the Future Sur5 vey published by the National Institute on 

6 Drug Abuse and the National Survey on 

7 Drug Use and Health by the Substance 

8 Abuse and Mental Health Service Adminis9 tration); or 

10 (ii) higher than the national average, 

11 as determined by the Attorney General (in12 cluding appropriate consideration of the 

13 surveys described in clause (i)), over a sus14 tained period of time; and 

15 (3) the term ‘‘local drug crisis’’ means, with re16 spect to the area served by an eligible entity— 

17 (A) a sudden increase in the abuse of pre18 scription medications, specifically opioids, as 

19 documented by local data; or 

20 (B) the abuse of prescription medications, 

21 specifically opioids, that is significantly higher 

22 than the national average, over a sustained pe23 riod of time, as documented by local data. 

mstockstill on DSK4VPTVN1PROD with BILLS

18 

•HR 5845 IH

1 (b) PROGRAM AUTHORIZED.—Section 1535 of chap2 ter 20 of the National Drug Control Program (21 U.S.C. 

3 chapter 20 subchapter II) is amended— 

4 (1) by adding subsection 1536 and inserting the 

5 following: 

6 ‘‘The Attorney General, in coordination with the Di7 rector of the Office of National Drug Control Policy, may 

8 make grants to eligible entities to implement comprehen9 sive community-wide strategies that address local drug cri10 ses within the area served by the eligible entity.’’. 

11 (c) APPLICATION.— 

12 (1) IN GENERAL.—An eligible entity desiring a 

13 grant under this section shall submit an application 

14 to the Attorney General at such time, in such man15 ner, and accompanied by such information as the 

16 Attorney General may require. 

17 (2) CRITERIA.—As part of an application for a 

18 grant under this section, the Attorney General shall 

19 require an eligible entity to submit a detailed, com20 prehensive, multisector plan for addressing the local 

21 drug crisis within the area served by the eligible en22 tity. 

23 (d) USE OF FUNDS.—An eligible entity shall use a 

24 grant received under this section— 

mstockstill on DSK4VPTVN1PROD with BILLS

19 

•HR 5845 IH

1 (1) for programs designed to implement com2 prehensive communitywide prevention strategies to 

3 address local drug crisis in the area served by the 

4 eligible entity, in accordance with the plan submitted 

5 under subsection (c)(2); and 

6 (2) to obtain specialized training and technical 

7 assistance from the organization funded under sec8 tion 4 of Public Law 107–82 (21 U.S.C. 1521 note). 

9 (e) GRANT AMOUNTS AND DURATION.— 

10 (1) AMOUNTS.—The Attorney General may not 

11 award a grant under this section for a fiscal year in 

12 an amount that exceeds— 

13 (A) the amount of non-Federal funds 

14 raised by the eligible entity, including in-kind 

15 contributions, for that fiscal year; or 

16 (B) $75,000. 

17 (2) DURATION.—The Attorney General shall 

18 award grants under this section for a period not to 

19 exceed 4 years. 

20 (f) SUPPLEMENT NOT SUPPLANT.—An eligible entity 

21 shall use Federal funds received under this section only 

22 to supplement the funds that would, in the absence of 

23 those Federal funds, be made available from other Federal 

24 and non-Federal sources for the activities described in this 

25 section, and not to supplant those funds. 

mstockstill on DSK4VPTVN1PROD with BILLS

20 

•HR 5845 IH

1 (g) EVALUATION.—A grant under this section shall 

2 be subject to the same evaluation requirements and proce3 dures as the evaluation requirements and procedures im4 posed on the recipient of a grant under the Drug-Free 

5 Communities Act of 1997. 

6 (h) LIMITATION ON ADMINISTRATIVE EXPENSES.— 

7 Not more than 8 percent of the amounts made available 

8 pursuant to subsection (i) for a fiscal year may be used 

9 by the Attorney General to pay for administrative ex10 penses. 

11 (i) AUTHORIZATION OF APPROPRIATIONS.—There 

12 are authorized to be appropriated to carry out this section 

13 $5,000,000 for each of fiscal years 2016 through 2020. 

14 TITLE II—LAW ENFORCEMENT 

15 AND TREATMENT 

16 SEC. 201. TREATMENT ALTERNATIVE TO INCARCERATION 

17 PROGRAMS. 

18 (a) PROGRAM AUTHORIZED.—Strike 3797(q), Drug 

19 Treatment Alternatives to Prison (42 U.S.C. chapter 46), 

20 and insert: 

21 (b) DEFINITIONS.—In this section— 

22 (1) the term ‘‘eligible entity’’ means a State, 

23 unit of local government, Indian tribe, or nonprofit 

24 organization; and 

mstockstill on DSK4VPTVN1PROD with BILLS

21 

•HR 5845 IH

1 (2) the term ‘‘eligible participant’’ means an in2 dividual who— 

3 (A) comes into contact with the criminal 

4 justice system or is charged with an offense; 

5 (B) has a history of or a current— 

6 (i) substance use disorder; 

7 (ii) mental illness; or 

8 (iii) co-occurring mental illness and 

9 substance use disorders; and 

10 (C) has been approved for participation in 

11 a program funded under this section by, as ap12 plicable depending on the stage of the criminal 

13 justice process, the relevant law enforcement 

14 agency or defense attorney, probation or correc15 tions official, judge, or representative from the 

16 relevant mental health or substance abuse agen17 cy. 

18 (c) PROGRAM AUTHORIZED.—The Attorney General 

19 may make grants to eligible entities to develop, implement, 

20 or expand a treatment alternative to incarceration pro21 gram for eligible participants, including— 

22 (1) pre-booking treatment alternative to incar23 ceration programs, including— 

mstockstill on DSK4VPTVN1PROD with BILLS

22 

•HR 5845 IH

1 (A) law enforcement training on substance 

2 use disorders, mental illness, and co-occurring 

3 mental illness and substance use disorders; 

4 (B) receiving centers as alternatives to in5 carceration of eligible participants; 

6 (C) specialized response units for calls re7 lated to substance use disorders, mental illness, 

8 and co-occurring mental illness and substance 

9 use disorders; and 

10 (D) other arrest and prebooking treatment 

11 alternative to incarceration models; and 

12 (2) postbooking treatment alternative to incar13 ceration programs, including— 

14 (A) specialized clinical case management; 

15 (B) pretrial services related to substances 

16 use disorders, mental illness, and co-occurring 

17 mental illness and substance use disorders; 

18 (C) prosecutor- and defender-based pro19 grams; 

20 (D) specialized probation; 

21 (E) treatment and rehabilitation programs; 

22 and 

23 (F) drug courts, DWI courts, and veterans 

24 treatment courts. 

25 (d) APPLICATION.— 

mstockstill on DSK4VPTVN1PROD with BILLS

23 

•HR 5845 IH

1 (1) IN GENERAL.—An eligible entity desiring a 

2 grant under this section shall submit an application 

3 to the Attorney General— 

4 (A) that meets the criteria under para5 graph (2); and 

6 (B) at such time, in such manner, and ac7 companied by such information as the Attorney 

8 General may require. 

9 (2) CRITERIA.—An eligible entity, in submitting 

10 an application under paragraph (1), shall— 

11 (A) provide extensive evidence of collabora12 tion with State and local government agencies 

13 overseeing health, community corrections, 

14 courts, prosecution, substance abuse, mental 

15 health, victims services, and employment serv16 ices, and with local law enforcement agencies; 

17 (B) demonstrate consultation with the Sin18 gle State Authority for Substance Abuse; 

19 (C) demonstrate that evidence-based treat20 ment practices will be utilized; and 

21 (D) demonstrate that evidenced-based 

22 screening and assessment tools will be utilized 

23 to place participants in the treatment alter24 native to incarceration program. 

mstockstill on DSK4VPTVN1PROD with BILLS

24 

•HR 5845 IH

1 (e) REQUIREMENTS.—Each eligible entity awarded a 

2 grant for a treatment alternative to incarceration program 

3 under this section shall— 

4 (1) determine the terms and conditions of par5 ticipation in the program by eligible participants, 

6 taking into consideration the collateral consequences 

7 of criminal conviction; 

8 (2) ensure that each substance abuse and men9 tal health treatment component is licensed and 

10 qualified by the relevant jurisdiction; 

11 (3) for programs described in subsection (b)(2), 

12 organize an enforcement unit comprised of appro13 priately trained law enforcement professionals under 

14 the supervision of the State, tribal, or local criminal 

15 justice agency involved, the duties of which shall in16 clude— 

17 (A) the verification of addresses and other 

18 contacts of each eligible participant who partici19 pates or desires to participate in the program; 

20 and 

21 (B) if necessary, the location, apprehen22 sion, arrest, and return to court of an eligible 

23 participant in the program who has absconded 

24 from the facility of a treatment provider or has 

25 otherwise violated the terms and conditions of 

mstockstill on DSK4VPTVN1PROD with BILLS

25 

•HR 5845 IH

1 the program, consistent with Federal and State 

2 confidentiality requirements; 

3 (4) notify the relevant criminal justice entity if 

4 any eligible participant in the program absconds 

5 from the facility of the treatment provider or other6 wise violates the terms and conditions of the pro7 gram, consistent with Federal and State confiden8 tiality requirements; 

9 (5) submit periodic reports on the progress of 

10 treatment or other measured outcomes from partici11 pation in the program of each eligible offender par12 ticipating in the program to the relevant State, trib13 al, or local criminal justice agency; 

14 (6) describe the evidence-based methodology 

15 and outcome measurements that will be used to 

16 evaluate the program, and specifically explain how 

17 such measurements will provide valid measures of 

18 the impact of the program; and 

19 (7) describe how the program could be broadly 

20 replicated if demonstrated to be effective. 

21 (f) USE OF FUNDS.—An eligible entity shall use a 

22 grant received under this section for expenses of a treat23 ment alternative to incarceration program, including— 

mstockstill on DSK4VPTVN1PROD with BILLS

26 

•HR 5845 IH

1 (1) salaries, personnel costs, equipment costs, 

2 and other costs directly related to the operation of 

3 the program, including the enforcement unit; 

4 (2) payments for treatment providers that are 

5 approved by the relevant State or tribal jurisdiction 

6 and licensed, if necessary, to provide needed treat7 ment to eligible offenders participating in the pro8 gram, including aftercare supervision, vocational 

9 training, education, and job placement; and 

10 (3) payments to public and nonprofit private 

11 entities that are approved by the State or tribal ju12 risdiction and licensed, if necessary, to provide alco13 hol and drug addiction treatment to eligible offend14 ers participating in the program. 

15 (g) SUPPLEMENT NOT SUPPLANT.—An eligible enti16 ty shall use Federal funds received under this section only 

17 to supplement the funds that would, in the absence of 

18 those Federal funds, be made available from other Federal 

19 and non-Federal sources for the activities described in this 

20 section, and not to supplant those funds. 

21 (h) GEOGRAPHIC DISTRIBUTION.—The Attorney 

22 General shall ensure that, to the extent practicable, the 

23 geographical distribution of grants under this section is 

24 equitable and includes a grant to an eligible entity in— 

25 (1) each State; 

mstockstill on DSK4VPTVN1PROD with BILLS

27 

•HR 5845 IH

1 (2) rural, suburban, and urban areas; and 

2 (3) tribal jurisdictions. 

3 (i) REPORTS AND EVALUATIONS.—Each fiscal year, 

4 each recipient of a grant under this section during that 

5 fiscal year shall submit to the Attorney General a report 

6 on the outcomes of activities carried out using that grant 

7 in such form, containing such information, and on such 

8 dates as the Attorney General shall specify. 

9 (j) AUTHORIZATION OF APPROPRIATIONS.—There 

10 are authorized to be appropriated to carry out this section 

11 $5,000,000 for each of fiscal years 2016 through 2020. 

12 SEC. 202. LAW ENFORCEMENT NALOXONE TRAINING AND 

13 IMPLEMENTATION PILOT. 

14 (a) DEFINITION.—In this section, the term ‘‘eligible 

15 entity’’ means a State, local, or tribal law enforcement 

16 agency. 

17 (b) PROGRAM AUTHORIZED.—Section 1177 of chap18 ter 16 of Drug Abuse Prevention, Treatment and Reha19 bilitation (21 U.S.C. chapter 16 subchapter IV) is amend20 ed— 

21 (1) by adding subsection 1177c and inserting 

22 the following: 

23 ‘‘(c) The Attorney General, in coordination with the 

24 Secretary of Health and the Attorney General, in coordi25 nation with the Secretary of Health and Human Services 

mstockstill on DSK4VPTVN1PROD with BILLS

28 

•HR 5845 IH

1 and the Director of the Office of National Drug Control 

2 Policy, may make grants to eligible entities to create a 

3 pilot law enforcement program to prevent opioid and her4 oin overdose death. 

5 ‘‘(d) APPLICATION.— 

6 ‘‘(1) IN GENERAL.—An eligible entity desiring a 

7 grant under this section shall submit an application 

8 to the Attorney General— 

9 ‘‘(A) that meets the criteria under para10 graph (2); and 

11 ‘‘(B) at such time, in such manner, and 

12 accompanied by such information as the Attor13 ney General may require. 

14 ‘‘(2) CRITERIA.—An eligible entity, in submit15 ting an application under paragraph (1), shall— 

16 ‘‘(A) describe the evidence-based method17 ology and outcome measurements that will be 

18 used to evaluate the program funded with a 

19 grant under this section, and specifically ex20 plain how such measurements will provide valid 

21 measures of the impact of the program; 

22 ‘‘(B) describe how the program could be 

23 broadly replicated if demonstrated to be effec24 tive; 

mstockstill on DSK4VPTVN1PROD with BILLS

29 

•HR 5845 IH

1 ‘‘(C) identify the governmental and com2 munity agencies that the program will coordi3 nate; and 

4 ‘‘(D) describe how law enforcement agen5 cies will coordinate with their corresponding 

6 State substance abuse agency to identify proto7 cols and resources that are available to victims 

8 and families, including information on treat9 ment and recovery resources. 

10 ‘‘(e) USE OF FUNDS.—An eligible entity shall use a 

11 grant received under this section to— 

12 ‘‘(1) make naloxone available to be carried and 

13 administered by law enforcement officers; 

14 ‘‘(2) train and provide resources for law en15 forcement officers on carrying and administering 

16 naloxone for the prevention of opioid and heroin 

17 overdose death; and 

18 ‘‘(3) establish processes, protocols, and mecha19 nisms for referral to treatment. 

20 ‘‘(f) GRANT AMOUNTS AND DURATION.— 

21 ‘‘(1) MAXIMUM AMOUNT.—The Attorney Gen22 eral may not award a grant under this section in an 

23 amount that exceeds $500,000. 

mstockstill on DSK4VPTVN1PROD with BILLS

30 

•HR 5845 IH

1 ‘‘(2) DURATION.—The Attorney General shall 

2 award grants under this section for a period not to 

3 exceed 2 years. 

4 ‘‘(g) TECHNICAL ASSISTANCE GRANTS.—The Attor5 ney General shall make a grant for the purpose of pro6 viding technical assistance and training on the use of 

7 naloxone to reverse overdose deaths and mechanisms for 

8 referral to treatment for an eligible entity receiving a 

9 grant under this section. 

10 ‘‘(h) EVALUATION.—The Attorney General shall con11 duct an evaluation of grants made under this section to 

12 determine— 

13 ‘‘(1) the number of officers equipped with 

14 naloxone for the prevention of fatal opioid and her15 oin overdose; 

16 ‘‘(2) the number of opioid and heroin overdoses 

17 reversed by officers receiving training and supplies 

18 of naloxone through a grant received under this sec19 tion; 

20 ‘‘(3) the number of calls for service related to 

21 opioid and heroin overdose; 

22 ‘‘(4) the extent to which overdose victims and 

23 families receive information about treatment services 

24 and available data describing treatment admissions; 

25 and 

mstockstill on DSK4VPTVN1PROD with BILLS

31 

•HR 5845 IH

1 ‘‘(5) the research, training, and naloxone supply 

2 needs of law enforcement and first responder agen3 cies, including those agencies that are not receiving 

4 grants under this section. 

5 ‘‘(i) AUTHORIZATION OF APPROPRIATIONS.—There 

6 are authorized to be appropriated to carry out this section 

7 $5,000,000 for each of fiscal years 2016 through 2020.’’. 

8 SEC. 203. PRESCRIPTION DRUG TAKE BACK EXPANSION. 

9 (a) DEFINITION.—In this section, the term ‘‘eligible 

10 entity’’ means a State, local, tribal law enforcement agen11 cy, public and private hospitals, pharmacies and other en12 tities approved for prescription drug disposal by the Drug 

13 Enforcement Agency. 

14 (b) PROGRAM AUTHORIZED.—Section 1177 of chap15 ter 16 of Drug Abuse Prevention, Treatment and Reha16 bilitation (21 U.S.C. chapter 16 subchapter IV) is amend17 ed— 

18 (1) by adding subsection 1177d and inserting 

19 the following: 

20 ‘‘(d) The Attorney General, in coordination with the 

21 Secretary of Health and the Attorney General, in coordi22 nation with the Administrator of the Drug Enforcement 

23 Administration, the Secretary of Health and Human Serv24 ices, and the Director of the Office of National Drug Con25 trol Policy, may make grants to eligible entities to expand 

mstockstill on DSK4VPTVN1PROD with BILLS

32 

•HR 5845 IH

1 or make available disposal sites for unwanted prescription 

2 medications.’’. 

3 (c) APPLICATION.— 

4 (1) IN GENERAL.—An eligible entity desiring a 

5 grant under this section shall submit an application 

6 to the Attorney General— 

7 (A) that meets the criteria under para8 graph (2); and 

9 (B) at such time, in such manner, and ac10 companied by such information as the Attorney 

11 General may require. 

12 (2) CRITERIA.—An eligible entity, in submitting 

13 an application under paragraph (1), shall— 

14 (A) describe the evidence-based method15 ology and outcome measurements that will be 

16 used to evaluate the program funded with a 

17 grant under this section, and specifically ex18 plain how such measurements will provide valid 

19 measures of the impact of the program; 

20 (B) describe how the program could be 

21 broadly replicated if demonstrated to be effec22 tive; and 

23 (C) identify the governmental and commu24 nity agencies that the project will be coordinate. 

mstockstill on DSK4VPTVN1PROD with BILLS

33 

•HR 5845 IH

1 (d) USE OF FUNDS.—An eligible entity shall use a 

2 grant received under this section for— 

3 (1) expenses of a prescription drug disposal 

4 site, including materials and resources; 

5 (2) implementing disposal procedures and proc6 esses; 

7 (3) implementing community education strate8 gies, including community education materials and 

9 resources; 

10 (4) replicating a prescription drug take back 

11 initiative throughout multiple jurisdictions; and 

12 (5) training of law enforcement officers and 

13 other community participants. 

14 (e) GRANT AMOUNTS AND DURATION.— 

15 (1) MAXIMUM AMOUNT.—The Attorney General 

16 may not award a grant under this section in an 

17 amount that exceeds $250,000. 

18 (2) DURATION.—The Attorney General shall 

19 award grants under this section for a period not to 

20 exceed 2 years. 

21 (f) TECHNICAL ASSISTANCE GRANT.—The Attorney 

22 General shall make a grant to a national nonprofit organi23 zation to provide technical assistance and training for an 

24 eligible entity receiving a grant under this section. 

25 (g) EVALUATION.— 

mstockstill on DSK4VPTVN1PROD with BILLS

34 

•HR 5845 IH

1 (1) IN GENERAL.—The Attorney General shall 

2 make a grant for evaluation of the performance of 

3 each eligible entity receiving a grant under this sec4 tion. 

5 (2) REPORTS.—Each fiscal year, the recipient 

6 of a grant under this subsection shall submit to the 

7 Attorney General a report on the effectiveness of the 

8 prescription drug take back program of each eligible 

9 entity receiving a grant under this section. 

10 (h) AUTHORIZATION OF APPROPRIATIONS.—There 

11 are authorized to be appropriated to carry out this section 

12 $2,500,000 for each of fiscal years 2016 through 2020. 

13 TITLE III—TREATMENT AND 

14 RECOVERY 

15 SEC. 301. EVIDENCE-BASED OPIOID AND HEROIN TREAT16 MENT AND INTERVENTIONS DEMONSTRA17 TION. 

18 Subpart 1 of part B of title V of the Public Health 

19 Service Act (42 U.S.C. 290bb et seq.) is amended— 

20 (1) by redesignating section 514 (42 U.S.C. 

21 290bb–9), as added by section 3632 of the Meth22 amphetamine Anti-Proliferation Act of 2000 (Public 

23 Law 106–310; 114 Stat. 1236), as section 514B; 

24 and 

25 (2) by adding at the end the following: 

mstockstill on DSK4VPTVN1PROD with BILLS

35 

•HR 5845 IH

1 ‘‘SEC. 514C. EVIDENCE-BASED OPIOID AND HEROIN TREAT2 MENT AND INTERVENTIONS DEMONSTRA3 TION. 

4 ‘‘(a) GRANTS.— 

5 ‘‘(1) AUTHORITY TO MAKE GRANTS.—The Di6 rector of the Center for Substance Abuse Treatment 

7 (referred to in this section as the ‘Director’) may 

8 award grants to State substance abuse agencies, 

9 units of local government, nonprofit organizations, 

10 and Indian tribes or tribal organizations (as defined 

11 in section 4 of the Indian Health Care Improvement 

12 Act (25 U.S.C. 1603)) that have a high rate, or 

13 have had a rapid increase, in the use of heroin or 

14 other opioids, in order to permit such entities to ex15 pand activities, including an expansion in the avail16 ability of medication assisted treatment, with respect 

17 to the treatment of addiction in the specific geo18 graphical areas of such entities where there is a rate 

19 or rapid increase in the use of heroin or other 

20 opioids. 

21 ‘‘(2) RECIPIENTS.—The entities receiving 

22 grants under paragraph (1) shall be selected by the 

23 Director. 

24 ‘‘(3) NATURE OF ACTIVITIES.—The grant funds 

25 awarded under paragraph (1) shall be used for ac26 tivities that are based on reliable scientific evidence 

mstockstill on DSK4VPTVN1PROD with BILLS

36 

•HR 5845 IH

1 of efficacy in the treatment of problems related to 

2 heroin or other opioids. 

3 ‘‘(b) GEOGRAPHIC DISTRIBUTION.—The Director 

4 shall ensure that grants awarded under subsection (a) are 

5 distributed equitably among the various regions of the Na6 tion and among rural, urban, and suburban areas that are 

7 affected by the use of heroin or other opioids. 

8 ‘‘(c) ADDITIONAL ACTIVITIES.—The Director shall— 

9 ‘‘(1) evaluate the activities supported by grants 

10 awarded under subsection (a); 

11 ‘‘(2) disseminate widely such significant infor12 mation derived from the evaluation as the Director 

13 considers appropriate; 

14 ‘‘(3) provide States, Indian tribes and tribal or15 ganizations, and providers with technical assistance 

16 in connection with the provision of treatment of 

17 problems related to heroin and other opioids; and 

18 ‘‘(4) fund only those applications that specifi19 cally support recovery services as a critical compo20 nent of the grant program. 

21 ‘‘(d) DEFINITION.—The term ‘medication assisted 

22 treatment’ means the use, for problems relating to heroin 

23 and other opioids, of medications approved by the Food 

24 and Drug Administration in combination with counseling 

25 and behavioral therapies. 

mstockstill on DSK4VPTVN1PROD with BILLS

37 

•HR 5845 IH

1 ‘‘(e) AUTHORIZATION OF APPROPRIATIONS.— 

2 ‘‘(1) IN GENERAL.—There are authorized to be 

3 appropriated to carry out this section $10,000,000 

4 for fiscal year 2016 and such sums as may be nec5 essary for each of fiscal years 2016 through 2020. 

6 ‘‘(2) USE OF CERTAIN FUNDS.—Of the funds 

7 appropriated to carry out this section in any fiscal 

8 year, the lesser of 5 percent of such funds or 

9 $1,000,000 shall be available to the Director for 

10 purposes of carrying out subsection (c).’’. 

11 SEC. 302. CRIMINAL JUSTICE MEDICATION ASSISTED 

12 TREATMENT AND INTERVENTIONS DEM13 ONSTRATION. 

14 (a) DEFINITIONS.—In this section— 

15 (1) the term ‘‘criminal justice agency’’ means a 

16 State, local, or tribal— 

17 (A) court; 

18 (B) prison; 

19 (C) jail; or 

20 (D) other agency that performs the admin21 istration of criminal justice, including prosecu22 tion, pretrial services, and community super23 vision; and 

24 (2) the term ‘‘eligible entity’’ means a State, 

25 unit of local government, or Indian tribe. 

mstockstill on DSK4VPTVN1PROD with BILLS

38 

•HR 5845 IH

1 (b) PROGRAM AUTHORIZED.—Section 1177 of chap2 ter 16 of Drug Abuse Prevention, Treatment and Reha3 bilitation (21 U.S.C. chapter 16 subchapter IV) is amend4 ed— 

5 by adding subsection 1177e and inserting the 

6 following: 

7 ‘‘(e) The Attorney General, in coordination with the 

8 Secretary of Health and the Attorney General, in coordi9 nation with the Secretary of Health and Human Services 

10 and the Director of the Office of National Drug Control 

11 Policy, may make grants to eligible entities to implement 

12 medication-assisted treatment programs through criminal 

13 justice agencies.’’. 

14 (c) APPLICATION.— 

15 (1) IN GENERAL.—An eligible entity desiring a 

16 grant under this section shall submit an application 

17 to the Attorney General— 

18 (A) that meets the criteria under para19 graph (2); and 

20 (B) at such time, in such manner, and ac21 companied by such information as the Attorney 

22 General may require. 

23 (2) CRITERIA.—An eligible entity, in submitting 

24 an application under paragraph (1), shall— 

mstockstill on DSK4VPTVN1PROD with BILLS

39 

•HR 5845 IH

1 (A) certify that each medication-assisted 

2 treatment program funded with a grant under 

3 this section has been developed in consultation 

4 with the Single State Authority for Substance 

5 Abuse; and 

6 (B) describe how data will be collected and 

7 analyzed to determine the effectiveness of the 

8 program described in subparagraph (A). 

9 (d) USE OF FUNDS.—An eligible entity shall use a 

10 grant received under this section for expenses of— 

11 (1) a medication-assisted treatment program, 

12 including the expenses of prescribing medications 

13 recognized by the Food and Drug Administration for 

14 opioid treatment in conjunction with psychological 

15 and behavioral therapy; 

16 (2) training criminal justice agency personnel 

17 and treatment providers on medication-assisted 

18 treatment; 

19 (3) cross-training personnel providing behav20 ioral health and health services, administration of 

21 medicines, and other administrative expenses, includ22 ing required reports; and 

23 (4) the provision of recovery coaches who are 

24 responsible for providing mentorship and transition 

mstockstill on DSK4VPTVN1PROD with BILLS

40 

•HR 5845 IH

1 plans to individuals reentering society following in2 carceration or alternatives to incarceration. 

3 (e) GRANT AMOUNTS AND DURATION.— 

4 (1) MAXIMUM AMOUNT.—The Attorney General 

5 may not award a grant under this section in an 

6 amount that exceeds $750,000. 

7 (2) DURATION.—The Attorney General shall 

8 award grants under this section for a period not to 

9 exceed 2 years. 

10 (f) TECHNICAL ASSISTANCE.—The Attorney General, 

11 in coordination with the Director of the National Institute 

12 on Drug Abuse and the Secretary of Health and Human 

13 Services, shall provide technical assistance and training 

14 for an eligible entity receiving a grant under this section. 

15 (g) REPORTS.— 

16 (1) IN GENERAL.—An eligible entity receiving a 

17 grant under this subsection shall submit a report to 

18 the Attorney General on the outcomes of each grant 

19 received under this section for individuals receiving 

20 medication-assisted treatment, based on— 

21 (A) the recidivism of the individuals; 

22 (B) the treatment outcomes of the individ23 uals, including maintaining abstinence from ille24 gal, unauthorized, and unprescribed opioids and 

25 heroin; 

mstockstill on DSK4VPTVN1PROD with BILLS

41 

•HR 5845 IH

1 (C) the housing status of the individuals; 

2 and 

3 (D) the employment status of the individ4 uals. 

5 (2) CONTENTS AND TIMING.—Each report de6 scribed in paragraph (1) shall be submitted annually 

7 in such form, containing such information, and on 

8 such dates as the Attorney General shall specify. 

9 (h) AUTHORIZATION OF APPROPRIATIONS.—There 

10 are authorized to be appropriated to carry out this section 

11 $5,000,000 for each of fiscal years 2016 through 2020. 

12 SEC. 303. NATIONAL YOUTH RECOVERY INITIATIVE. 

13 (a) DEFINITIONS.—In this section: 

14 (1) ELIGIBLE ENTITY.—The term ‘‘eligible enti15 ty’’ means— 

16 (A) a high school that has been accredited 

17 as a recovery high school by the Association of 

18 Recovery High Schools; 

19 (B) an accredited high school that is seek20 ing to establish or expand recovery support 

21 services; 

22 (C) an institution of higher education; 

23 (D) a recovery program at a nonprofit col24 legiate institution; or 

25 (E) a nonprofit organization. 

mstockstill on DSK4VPTVN1PROD with BILLS

42 

•HR 5845 IH

1 (2) INSTITUTION OF HIGHER EDUCATION.—The 

2 term ‘‘institution of higher education’’ has the 

3 meaning given the term in section 101 of the Higher 

4 Education Act of 1965 (20 U.S.C. 1001). 

5 (3) RECOVERY PROGRAM.—The term ‘‘recovery 

6 program’’— 

7 (A) means a program to help individuals 

8 who are recovering from substance use dis9 orders to initiate, stabilize, and maintain 

10 healthy and productive lives in the community; 

11 and 

12 (B) includes peer-to-peer support and com13 munal activities to build recovery skills and 

14 supportive social networks. 

15 (b) GRANTS AUTHORIZED.—Section 1177 of chapter 

16 16 of Drug Abuse Prevention, Treatment and Rehabilita17 tion (21 U.S.C. chapter 16 subchapter IV) is amended— 

18 (1) by adding subsection 1177f and inserting 

19 the following: 

20 ‘‘The Attorney General, in coordination with the Sec21 retary of Health and the ONDCP Recovery Branch, in 

22 consultation with the Secretary of Education, may award 

23 grants to eligible entities to enable the entities to— 

mstockstill on DSK4VPTVN1PROD with BILLS

43 

•HR 5845 IH

1 ‘‘(1) provide substance use recovery support 

2 services to young people in high school and enrolled 

3 in institutions of higher education; 

4 ‘‘(2) help build communities of support for 

5 young people in recovery through a spectrum of ac6 tivities such as counseling and healthy and wellness7 oriented social activities; and 

8 ‘‘(3) encourage initiatives designed to help 

9 young people achieve and sustain recovery from sub10 stance use disorders.’’. 

11 (c) USE OF FUNDS.—Grants awarded under sub12 section (b) may be used for activities to develop, support, 

13 and maintain youth recovery support services, including— 

14 (1) the development and maintenance of a dedi15 cated physical space for recovery programs; 

16 (2) dedicated staff for the provision of recovery 

17 programs; 

18 (3) healthy and wellness-oriented social activi19 ties and community engagement; 

20 (4) establishment of recovery high schools; 

21 (5) coordination of recovery programs with— 

22 (A) substance use disorder treatment pro23 grams and systems; 

24 (B) primary care providers; 

mstockstill on DSK4VPTVN1PROD with BILLS

44 

•HR 5845 IH

1 (C) the criminal justice system, including 

2 the juvenile justice system; 

3 (D) employers; 

4 (E) housing services; 

5 (F) child welfare services; 

6 (G) institutions of secondary higher edu7 cation and institutions of higher education; and 

8 (H) other programs or services related to 

9 the welfare of an individual in recovery from a 

10 substance use disorder; 

11 (6) the development of peer-to-peer support 

12 programs or services; and 

13 (7) additional activities that help youths and 

14 young adults to achieve recovery from substance use 

15 disorders. 

16 (d) RESOURCE CENTER.—The ONDCP Recovery 

17 Branch shall establish a resource center to provide tech18 nical support to recipients of grants under this section. 

19 (e) AUTHORIZATION OF APPROPRIATIONS.—There 

20 are authorized to be appropriated to carry out this section 

21 $3,000,000 for fiscal year 2016 and each of the 5 suc22 ceeding fiscal years. 

mstockstill on DSK4VPTVN1PROD with BILLS

45 

•HR 5845 IH

1 SEC. 304. BUILDING COMMUNITIES OF RECOVERY. 

2 (a) DEFINITION.—In this section, the term ‘‘recovery 

3 community organization’’ means an independent nonprofit 

4 organization that— 

5 (1) mobilizes resources within and outside of 

6 the recovery community to increase the prevalence 

7 and quality of long-term recovery from substance 

8 use disorders; and 

9 (2) is wholly or principally governed by people 

10 in recovery for substance use disorders who reflect 

11 the community served. 

12 (b) GRANTS AUTHORIZED.—Section 1177 of chapter 

13 16 of Drug Abuse Prevention, Treatment and Rehabilita14 tion (21 U.S.C. chapter 16 subchapter IV) is amended— 

15 (1) by adding subsection 1177g and inserting 

16 the following: 

17 ‘‘The Attorney General, in coordination with the Sec18 retary of Health and the ONDCP Recovery Branch, in 

19 consultation with the Substance Abuse and Mental Health 

20 Services Administration, may award grants to recovery 

21 community organizations to enable such organizations to 

22 develop, expand, and enhance recovery services.’’. 

23 (c) MAXIMUM GRANT AMOUNT.—The ONDCP Re24 covery Branch may not award a grant under this section 

25 in an amount that exceeds $200,000. 

mstockstill on DSK4VPTVN1PROD with BILLS

46 

•HR 5845 IH

1 (d) FEDERAL SHARE.—The Federal share of the 

2 costs of a program funded by a grant under this section 

3 may not exceed 50 percent. 

4 (e) USE OF FUNDS.—Grants awarded under sub5 section (b)— 

6 (1) shall be used to develop, expand, and en7 hance community and statewide recovery support 

8 services; and 

9 (2) may be used to— 

10 (A) advocate for individuals in recovery 

11 from substance use disorders; 

12 (B) build connections between recovery 

13 networks, between recovery community organi14 zations, and with other recovery support serv15 ices, including— 

16 (i) substance use disorder treatment 

17 programs and systems; 

18 (ii) primary care providers; 

19 (iii) the criminal justice system; 

20 (iv) employers; 

21 (v) housing services; 

22 (vi) child welfare agencies; and 

23 (vii) other recovery support services 

24 that facilitate recovery from substance use 

25 disorders; 

mstockstill on DSK4VPTVN1PROD with BILLS

47 

•HR 5845 IH

1 (C) reduce the stigma associated with sub2 stance use disorders; 

3 (D) conduct public education and outreach 

4 on issues relating to substance use disorders 

5 and recovery, including— 

6 (i) how to identify the signs of addic7 tion; 

8 (ii) the resources that are available 

9 for individuals struggling with addiction; 

10 (iii) the resources that are available to 

11 help support individuals in recovery; and 

12 (iv) information on the medical con13 sequences of substance use disorders, in14 cluding neonatal abstinence syndrome and 

15 potential infection with human immuno16 deficiency virus and viral hepatitis; and 

17 (E) carry out other activities that 

18 strengthen the network of community support 

19 for individuals in recovery. 

20 (f) RESOURCE CENTER.—The ONDCP Recovery 

21 Branch shall establish a resource center to provide tech22 nical assistance to recipients of grants under this section 

23 and to provide information to individuals seeking to sup24 port people in recovery from substance use disorders. 

mstockstill on DSK4VPTVN1PROD with BILLS

48 

•HR 5845 IH

1 (g) AUTHORIZATION OF APPROPRIATIONS.—There 

2 are authorized to be appropriated to carry out this section 

3 $50,700,000 in fiscal year 2016 and each of the 3 suc4 ceeding fiscal years. 

5 TITLE IV—ADDRESSING 

6 COLLATERAL CONSEQUENCES 

7 SEC. 401. CORRECTIONAL EDUCATION DEMONSTRATION 

8 GRANT PROGRAM. 

9 Title I of the Omnibus Crime Control and Safe 

10 Streets Act of 1968 (42 U.S.C. 3711 et seq.) is amend11 ed— 

12 (1) by redesignating part KK as part LL; and 

13 (2) by inserting before part LL, as redesig14 nated, the following: 

15 ‘‘PART KK—CORRECTIONAL EDUCATION 

16 DEMONSTRATION GRANT PROGRAM 

17 ‘‘SEC. 3001. CORRECTIONAL EDUCATION DEMONSTRATION 

18 GRANT PROGRAM. 

19 ‘‘(a) DEFINITION.—In this section, the term ‘eligible 

20 entity’ means a State, unit of local government, nonprofit 

21 organization, or Indian tribe. 

22 ‘‘(b) GRANT PROGRAM AUTHORIZED.—The Attorney 

23 General may make grants of not more than $750,000 to 

24 eligible entities to design, implement, and expand edumstockstill on DSK4VPTVN1PROD with BILLS

49 

•HR 5845 IH

1 cational programs for offenders in prisons, jails, and juve2 nile facilities, including to pay for— 

3 ‘‘(1) basic education, secondary level academic 

4 education, high school equivalency examination prep5 aration, career technical education, and English as 

6 a second language instruction at the basic, sec7 ondary, or postsecondary levels, for adult and juve8 nile populations; 

9 ‘‘(2) screening and assessment of inmates to as10 sess education level, needs, occupational interest or 

11 aptitude, risk level, and other needs, and case man12 agement services; 

13 ‘‘(3) hiring and training of instructors and 

14 aides, reimbursement of noncorrections staff and ex15 perts, reimbursement of stipends paid to inmate tu16 tors or aides, and the costs of training inmate tutors 

17 and aides; 

18 ‘‘(4) instructional supplies and equipment, in19 cluding occupational program supplies and equip20 ment to the extent that the supplies and equipment 

21 are used for instructional purposes; 

22 ‘‘(5) partnerships and agreements with commu23 nity colleges, universities, and career technology edu24 cation program providers, including tuition pay25 ments; 

mstockstill on DSK4VPTVN1PROD with BILLS

50 

•HR 5845 IH

1 ‘‘(6) certification programs providing recognized 

2 high school equivalency certificates and industry rec3 ognized credentials; and 

4 ‘‘(7) technology solutions to— 

5 ‘‘(A) meet the instructional, assessment, 

6 and information needs of correctional popu7 lations; and 

8 ‘‘(B) facilitate the continued participation 

9 of incarcerated students in community-based 

10 education programs after the students are re11 leased from incarceration. 

12 ‘‘(c) APPLICATION.—An eligible entity desiring a 

13 grant under this section shall submit to the Attorney Gen14 eral an application in such form and manner, at such time, 

15 and accompanied by such information as the Attorney 

16 General specifies. 

17 ‘‘(d) PRIORITY CONSIDERATIONS.—In awarding 

18 grants under this section, the Attorney General shall give 

19 priority to applicants that— 

20 ‘‘(1) assess the level of risk and need of in21 mates, including by— 

22 ‘‘(A) assessing the need for English as a 

23 second language instruction; 

24 ‘‘(B) conducting educational assessments; 

25 and 

mstockstill on DSK4VPTVN1PROD with BILLS

51 

•HR 5845 IH

1 ‘‘(C) assessing occupational interests and 

2 aptitudes; 

3 ‘‘(2) target educational services to assessed 

4 needs, including academic and occupational at the 

5 basic, secondary, or postsecondary level; 

6 ‘‘(3) target career technology education pro7 grams to— 

8 ‘‘(A) areas of identified occupational de9 mand; and 

10 ‘‘(B) employment opportunities in the com11 munities in which students are reasonably ex12 pected to reside postrelease; 

13 ‘‘(4) include a range of appropriate educational 

14 opportunities at the basic, secondary, and postsec15 ondary levels; 

16 ‘‘(5) include opportunities for students to attain 

17 industry-recognized credentials; 

18 ‘‘(6) include partnership or articulation agree19 ments linking institutional education programs with 

20 community-sited programs provided by adult edu21 cation program providers and accredited institutions 

22 of higher education, community colleges, and voca23 tional training institutions; and 

24 ‘‘(7) explicitly include career pathways models 

25 offering opportunities for incarcerated students to 

mstockstill on DSK4VPTVN1PROD with BILLS

52 

•HR 5845 IH

1 develop academic skills, in-demand occupational 

2 skills and credentials, occupational experience in in3 stitutional work programs or work release programs, 

4 and linkages with employers in the community, so 

5 that incarcerated students have opportunities to em6 bark on careers with strong prospects for both post7 release employment and advancement in a career 

8 ladder over time. 

9 ‘‘(e) REQUIREMENTS.—An eligible entity desiring a 

10 grant under this section shall— 

11 ‘‘(1) describe the evidence-based methodology 

12 and outcome measurements that will be used to 

13 evaluate each program funded with a grant under 

14 this section, and specifically explain how such meas15 urements will provide valid measures of the impact 

16 of the program; and 

17 ‘‘(2) describe how the program described in 

18 paragraph (1) could be broadly replicated if dem19 onstrated to be effective. 

20 ‘‘(f) CONTROL OF INTERNET ACCESS.—An entity 

21 that receives a grant under this section shall restrict ac22 cess to the Internet by prisoners, as appropriate, to ensure 

23 public safety. 

mstockstill on DSK4VPTVN1PROD with BILLS

53 

•HR 5845 IH

1 ‘‘SEC. 3002. AUTHORIZATION OF APPROPRIATIONS. 

2 ‘‘There are authorized to be appropriated $5,000,000 

3 to carry out this part for fiscal years 2016 through 

4 2020.’’. 

5 SEC. 402. REVISION OF FAFSA FORM. 

6 Section 483 of the Higher Education Act of 1965 (20 

7 U.S.C. 1090) is amended by adding at the end the fol8 lowing: 

9 ‘‘(i) CONVICTIONS.—The Secretary shall not include 

10 any question about the conviction of an applicant for the 

11 possession or sale of illegal drugs on the FAFSA (or any 

12 other form developed under subsection (a)).’’. 

13 SEC. 403. NATIONAL TASK FORCE ON RECOVERY AND COL14 LATERAL CONSEQUENCES. 

15 (a) DEFINITION.—In this section, the term ‘‘collat16 eral consequence’’ means a penalty, disability, or dis17 advantage— 

18 (1) imposed on an individual as a result of a 

19 criminal conviction but not as part of the judgment 

20 of the court that imposes the conviction; or 

21 (2) that an administrative agency, official, or 

22 civil court is authorized, but not required, to impose 

23 on an individual convicted of a felony, misdemeanor, 

24 or other criminal offense. 

25 (b) ESTABLISHMENT.— 

mstockstill on DSK4VPTVN1PROD with BILLS

54 

•HR 5845 IH

1 (1) IN GENERAL.—Not later than 30 days after 

2 the date of enactment of this Act, the Secretary of 

3 Health and Human Services (in this section referred 

4 to as the ‘‘Secretary’’) shall establish a bipartisan 

5 task force to be known as the Task Force on Recov6 ery and Collateral Consequences (in this section re7 ferred to as the ‘‘Task Force’’). 

8 (2) MEMBERSHIP.— 

9 (A) TOTAL NUMBER OF MEMBERS.—The 

10 Task Force shall include 9 members, who shall 

11 be appointed by the Secretary in accordance 

12 with subparagraphs (B) and (C). 

13 (B) MEMBERS OF THE TASK FORCE.—The 

14 Task Force shall include— 

15 (i) members who have national rec16 ognition and significant expertise in areas 

17 such as health care, housing, employment, 

18 substance use disorder, law enforcement, 

19 and law; 

20 (ii) not less than 1 member who has 

21 personally experienced addiction and is in 

22 recovery; and 

23 (iii) to the extent practicable, mem24 bers who formerly served as elected offi25 cials at the State and Federal levels. 

mstockstill on DSK4VPTVN1PROD with BILLS

55 

•HR 5845 IH

1 (C) TIMING.—The Secretary shall appoint 

2 the members of the Task Force not later than 

3 60 days after date on which the Task Force is 

4 established under paragraph (1). 

5 (3) CHAIRPERSON.—The Task Force shall se6 lect a chairperson or co-chairpersons from among 

7 the members of the Task Force. 

8 (c) DUTIES OF THE TASK FORCE.— 

9 (1) IN GENERAL.—The Task Force shall— 

10 (A) identify collateral consequences for in11 dividuals with Federal or State drug convictions 

12 who are in recovery for substance use disorder; 

13 and 

14 (B) determine whether the collateral con15 sequences identified under subparagraph (A) 

16 unnecessarily delay individuals in recovery from 

17 resuming their personal and professional activi18 ties. 

19 (2) RECOMMENDATIONS.—Not later than 180 

20 days after the date of the first meeting of the Task 

21 Force, the Task Force shall develop recommenda22 tions for proposed legislative and regulatory changes 

23 to reduce and, to the extent practicable, eliminate 

24 the collateral consequences identified by the Task 

25 Force under paragraph (1). 

mstockstill on DSK4VPTVN1PROD with BILLS

56 

•HR 5845 IH

1 (3) COLLECTION OF INFORMATION.—The Task 

2 Force shall hold hearings, require the testimony and 

3 attendance of witnesses, and secure information 

4 from any department or agency of the United States 

5 in performing the duties under paragraphs (1) and 

6 (2). 

7 (4) REPORT.—Not later than 1 year after the 

8 date of the first meeting of the Task Force, the 

9 Task Force shall submit a report detailing the find10 ings and recommendations of the Task Force to— 

11 (A) each relevant committee of Congress; 

12 (B) the head of each relevant department 

13 or agency of the United States; 

14 (C) the President; and 

15 (D) the Vice President. 

16 TITLE V—ADDICTION AND 

17 TREATMENT SERVICES FOR 

18 WOMEN, FAMILIES, AND VET19 ERANS 

20 SEC. 501. AUTHORITY TO AWARD COMPETITIVE GRANTS TO 

21 ADDRESS OPIOID AND HEROIN ABUSE BY 

22 PREGNANT AND PARENTING FEMALE OF23 FENDERS. 

24 (a) DEFINITIONS.—In this section— 

mstockstill on DSK4VPTVN1PROD with BILLS

57 

•HR 5845 IH

1 (1) the term ‘‘State criminal justice agency’’ 

2 means the agency of the State responsible for ad3 ministering criminal justice funds, including the Ed4 ward Byrne Memorial Justice Assistance Grant Pro5 gram under subpart 1 of part E of title I of the Om6 nibus Crime Control and Safe Streets Act of 1968 

7 (42 U.S.C. 3750 et seq.); and 

8 (2) the term ‘‘State substance abuse agency’’ 

9 means the agency of the State responsible for the 

10 State prevention, treatment, and recovery system, 

11 including management of the Substance Abuse Pre12 vention and Treatment Block Grant under subpart 

13 II of part B of title XIX of the Public Health Serv14 ice Act (42 U.S.C. 300x–21 et seq.). 

15 (b) PURPOSE AND PROGRAM AUTHORITY.— 

16 (1) GRANT AUTHORIZATION.—Section 1177 of 

17 chapter 16 of Drug Abuse Prevention, Treatment 

18 and Rehabilitation (21 U.S.C. chapter 16 subchapter 

19 IV) is amended— 

20 (1) by adding subsection 1177h and inserting 

21 the following: 

22 ‘‘The Attorney General, in coordination with the Sec23 retary of Health and the Attorney General may award 

24 competitive grants jointly to a State substance abuse 

25 agency and a State criminal justice agency to address the 

mstockstill on DSK4VPTVN1PROD with BILLS

58 

•HR 5845 IH

1 use of opioids and heroin among pregnant and parenting 

2 female offenders in the State to promote public safety, 

3 public health, family permanence, and wellbeing.’’. 

4 (2) PURPOSES AND PROGRAM AUTHORITY.—A 

5 grant under this section shall be used to facilitate or 

6 enhance collaboration between the State criminal 

7 justice and State substance abuse systems in order 

8 to carry out programs to address the use of opioid 

9 and heroin abuse by pregnant and parenting female 

10 offenders. 

11 (c) APPLICATIONS.— 

12 (1) IN GENERAL.—A State substance abuse 

13 agency and State criminal justice agency desiring a 

14 grant under this section shall jointly submit to the 

15 Attorney General an application in such form, and 

16 containing such information, as the Attorney Gen17 eral may prescribe by regulation or guidelines. 

18 (2) CONTENTS.— 

19 (A) IN GENERAL.—Each application for a 

20 grant under this section shall contain a plan to 

21 expand the services of the State for pregnant 

22 and parenting female offenders for the use of 

23 opioids, heroin, and other drugs, which shall be 

24 in accordance with regulations or guidelines es25 tablished by the Attorney General, in consultamstockstill on DSK4VPTVN1PROD with BILLS

59 

•HR 5845 IH

1 tion with the Secretary of Health and Human 

2 Services. 

3 (B) PLAN.—A plan submitted under sub4 paragraph (A) shall, at a minimum, include— 

5 (i) a description of how the applicants 

6 will work jointly to address the needs asso7 ciated with the use of opioids or heroin by 

8 pregnant and parenting female offenders 

9 to promote family stability and perma10 nence; 

11 (ii) a description of the nature and 

12 the extent of the problem of opioid and 

13 heroin use by pregnant and parenting fe14 male offenders in the State; 

15 (iii) a certification that the State has 

16 involved counties and other units of local 

17 government, when appropriate, in the de18 velopment, expansion, modification, oper19 ation, or improvement of proposed pro20 grams to address the problems associated 

21 with opioid and heroin use; 

22 (iv) a certification that funds received 

23 under this section will be used to supple24 ment, not supplant, other Federal, State, 

25 and local funds; and 

mstockstill on DSK4VPTVN1PROD with BILLS

60 

•HR 5845 IH

1 (v) a description of clinically appro2 priate practices and procedures to— 

3 (I) screen and assess pregnant 

4 and parenting female offenders for 

5 problems associated with opioids and 

6 heroin; 

7 (II) provide clinically appropriate 

8 services, including medication-assisted 

9 treatment, for female offenders and 

10 their children in the same location to 

11 promote family permanence and self12 sufficiency; and 

13 (III) provide for a process to en14 hance or ensure the abilities of the 

15 State criminal justice agency and 

16 State substance abuse agency to work 

17 together to reunite families when ap18 propriate in the case where family 

19 treatment is not provided. 

20 (d) PERIOD OF GRANT; RENEWAL.— 

21 (1) PERIOD.—A grant under this section shall 

22 be for a period of 3 years. 

23 (2) RENEWAL.—A State substance abuse agen24 cy and a State criminal justice agency receiving a 

25 grant under this section may apply for and, after the 

mstockstill on DSK4VPTVN1PROD with BILLS

61 

•HR 5845 IH

1 end of the period of the first grant under this sec2 tion, receive 1 additional grant under this section. 

3 (e) PERFORMANCE ACCOUNTABILITY; REPORTS.— 

4 (1) REPORTS.—A State substance abuse agency 

5 and a State criminal justice agency receiving a grant 

6 under this section shall jointly submit to the Attor7 ney General a report on the activities carried out 

8 under the grant at the end of each fiscal year during 

9 the period of the grant. 

10 (2) EVALUATION.—Not later than 1 year after 

11 the end of the period of a grant under this section, 

12 the Attorney General shall submit a report to each 

13 committee of Congress with jurisdiction of the pro14 gram under this section that summarizes the reports 

15 of the recipients of the grant and provides rec16 ommendations, if any, for further legislative action. 

17 (f) TRAINING AND TECHNICAL ASSISTANCE.—The 

18 Attorney General shall support State substance abuse and 

19 State criminal justice agencies by developing, in consulta20 tion with State substance abuse and State criminal justice 

21 agencies, and offering a program of training and technical 

22 assistance to assist the agencies in developing programs 

23 and protocols— 

24 (1) to implement this section; and 

mstockstill on DSK4VPTVN1PROD with BILLS

62 

•HR 5845 IH

1 (2) for effectively working across the Federal 

2 and State criminal and substance abuse systems. 

3 (g) AUTHORIZATION OF APPROPRIATIONS.—There 

4 are authorized to be appropriated to carry out this section 

5 $5,000,000 for each of fiscal years 2016 through 2020. 

6 SEC. 502. GRANTS FOR FAMILY-BASED SUBSTANCE ABUSE 

7 TREATMENT. 

8 Section 2925 of the Omnibus Crime Control and Safe 

9 Streets Act of 1968 (42 U.S.C. 3797s–4) is amended— 

10 (1) by striking ‘‘An entity’’ and inserting ‘‘(a) 

11 ENTITY REPORTS.—An entity’’; and 

12 (2) by adding at the end the following: 

13 ‘‘(b) ATTORNEY GENERAL REPORT ON FAMILY14 BASED SUBSTANCE ABUSE TREATMENT.—The Attorney 

15 General shall submit to Congress an annual report that 

16 describes the number of grants awarded under section 

17 2921(1) and how such grants are used by the recipients 

18 for family-based substance abuse treatment programs that 

19 serve as alternatives to incarceration for custodial parents 

20 to receive treatment and services as a family.’’. 

21 SEC. 503. VETERANS’ TREATMENT COURTS. 

22 Section 2991 of the Omnibus Crime Control and Safe 

23 Streets Act of 1968 (42 U.S.C. 3797aa) is amended— 

24 (1) by redesignating subsection (i) as subsection 

25 (j); 

mstockstill on DSK4VPTVN1PROD with BILLS

63 

•HR 5845 IH

1 (2) by inserting after subsection (h) the fol2 lowing: 

3 ‘‘(i) ASSISTING VETERANS.— 

4 ‘‘(1) DEFINITIONS.—In this subsection: 

5 ‘‘(A) PEER-TO-PEER SERVICES OR PRO6 GRAMS.—The term ‘peer-to-peer services or pro7 grams’ means services or programs that connect 

8 qualified veterans with other veterans for the 

9 purpose of providing support and mentorship to 

10 assist qualified veterans in obtaining treatment, 

11 recovery, stabilization, or rehabilitation. 

12 ‘‘(B) QUALIFIED VETERAN.—The term 

13 ‘qualified veteran’ means a preliminarily quali14 fied offender who— 

15 ‘‘(i) has served on active duty in any 

16 branch of the Armed Forces, including the 

17 National Guard and reserve components; 

18 and 

19 ‘‘(ii) was discharged or released from 

20 such service under conditions other than 

21 dishonorable. In circumstances where dis22 charged dishonorably due to drug use a 

23 waiver into the program may be permitted. 

24 ‘‘(C) VETERANS TREATMENT COURT PRO25 GRAM.—The term ‘veterans treatment court 

mstockstill on DSK4VPTVN1PROD with BILLS

64 

•HR 5845 IH

1 program’ means a court program involving col2 laboration among criminal justice, veterans, and 

3 mental health and substance abuse agencies 

4 that provides qualified veterans with— 

5 ‘‘(i) intensive judicial supervision and 

6 case management, which may include ran7 dom and frequent drug testing where ap8 propriate; 

9 ‘‘(ii) a full continuum of treatment 

10 services, including mental health services, 

11 substance abuse services, medical services, 

12 and services to address trauma; 

13 ‘‘(iii) alternatives to incarceration; 

14 and 

15 ‘‘(iv) other appropriate services, in16 cluding housing, transportation, mentoring, 

17 employment, job training, education, and 

18 assistance in applying for and obtaining 

19 available benefits. 

20 ‘‘(2) VETERANS ASSISTANCE PROGRAM.— 

21 ‘‘(A) IN GENERAL.—The Attorney General, 

22 in consultation with the Secretary of Veterans 

23 Affairs, may award grants under this sub24 section to applicants to establish or expand— 

mstockstill on DSK4VPTVN1PROD with BILLS

65 

•HR 5845 IH

1 ‘‘(i) veterans treatment court pro2 grams; 

3 ‘‘(ii) peer-to-peer services or programs 

4 for qualified veterans; 

5 ‘‘(iii) practices that identify and pro6 vide treatment, rehabilitation, legal, transi7 tional, and other appropriate services to 

8 qualified veterans who have been incarcer9 ated; and 

10 ‘‘(iv) training programs to teach 

11 criminal justice, law enforcement, correc12 tions, mental health, and substance abuse 

13 personnel how to identify and appro14 priately respond to incidents involving 

15 qualified veterans. 

16 ‘‘(B) PRIORITY.—In awarding grants 

17 under this subsection, the Attorney General 

18 shall give priority to applications that— 

19 ‘‘(i) demonstrate collaboration be20 tween and joint investments by criminal 

21 justice, mental health, substance abuse, 

22 and veterans service agencies; 

23 ‘‘(ii) promote effective strategies to 

24 identify and reduce the risk of harm to 

25 qualified veterans and public safety; and 

mstockstill on DSK4VPTVN1PROD with BILLS

66 

•HR 5845 IH

1 ‘‘(iii) propose interventions with em2 pirical support to improve outcomes for 

3 qualified veterans.’’; and 

4 (3) in subsection (j), as so redesignated— 

5 (A) by redesignating paragraph (2) as 

6 paragraph (3); and 

7 (B) by inserting after paragraph (1) the 

8 following: 

9 ‘‘(2) VETERANS TREATMENT COURTS.—In addi10 tion to the amounts authorized under paragraph (1), 

11 there are authorized to be appropriated to the Attor12 ney General $5,000,000 for each of fiscal years 

13 2016 through 2020 to carry out subsection (i).’’. 

14 TITLE VI—INCENTIVIZING STATE 

15 COMPREHENSIVE INITIA16 TIVES TO ADDRESS OPIOID 

17 AND HEROIN ABUSE 

18 SEC. 601. STATE DEMONSTRATION GRANTS FOR COM19 PREHENSIVE OPIOID ABUSE RESPONSE. 

20 (a) DEFINITIONS.—In this section— 

21 (1) the term ‘‘civil liability protection law’’ 

22 means a State law that protects from civil liability 

23 individuals who give aid on a voluntary basis in an 

24 emergency to individuals who are ill, in peril, or oth25 erwise incapacitated; 

mstockstill on DSK4VPTVN1PROD with BILLS

67 

•HR 5845 IH

1 (2) the term ‘‘dispenser’’ has the meaning given 

2 the term in section 102 of the Controlled Substances 

3 Act (21 U.S.C. 802); 

4 (3) the term ‘‘prescriber of a schedule II, III, 

5 or IV controlled substance’’ does not include a pre6 scriber of a schedule II, III, or IV controlled sub7 stance that dispenses the substance— 

8 (A) for use on the premises on which the 

9 substance is dispensed; 

10 (B) in a hospital emergency room, when 

11 the substance is in short supply; 

12 (C) for a certified opioid treatment pro13 gram; or 

14 (D) in other situations as the Attorney 

15 General may reasonably determine; 

16 (4) the term ‘‘prescriber’’ means a dispenser 

17 who prescribes a controlled substance, or the agent 

18 of such a dispenser; and 

19 (5) the term ‘‘schedule II, III, or IV controlled 

20 substance’’ means a controlled substance that is list21 ed on schedule II, schedule III, or schedule IV of 

22 section 202(c) of the Controlled Substances Act (21 

23 U.S.C. 812(c)). 

24 (b) PROGRAM AUTHORIZED.—Section 1177 of chap25 ter 16 of Drug Abuse Prevention, Treatment and Rehamstockstill on DSK4VPTVN1PROD with BILLS

68 

•HR 5845 IH

1 bilitation (21 U.S.C. chapter 16 subchapter IV) is amend2 ed— 

3 (1) by adding subsection 1177i and inserting 

4 the following: 

5 ‘‘THE ATTORNEY GENERAL, IN COORDINATION

6 WITH THE SECRETARY OF HEALTH AND PLANNING AND

7 IMPLEMENTATION GRANTS.— 

8 ‘‘(1) IN GENERAL.—The Attorney General, in 

9 coordination with the Secretary of Health and 

10 Human Services and the Director of the Office of 

11 National Drug Control Policy, may award grants to 

12 States, and combinations thereof, to prepare a com13 prehensive plan for and implement an integrated 

14 opioid abuse response initiative. 

15 ‘‘(2) PURPOSES.—A State receiving a grant 

16 under this section shall establish a comprehensive 

17 response to opioid abuse, which shall include— 

18 ‘‘(A) prevention and education efforts 

19 around heroin and opioid use, treatment, and 

20 recovery; 

21 ‘‘(B) a comprehensive prescription drug 

22 monitoring program to track dispensing of 

23 schedule II, III, or IV controlled substances, 

24 which shall include— 

mstockstill on DSK4VPTVN1PROD with BILLS

69 

•HR 5845 IH

1 ‘‘(i) data sharing with other States by 

2 statute, regulation, or interstate agree3 ment; 

4 ‘‘(ii) educating physicians, residents, 

5 medical students, and other prescribers of 

6 schedule II, III, or IV controlled sub7 stances on the prescription drug moni8 toring program of the State; 

9 ‘‘(C) developing, implementing, or expand10 ing the prescription drug and opioid addiction 

11 treatment program of the State by— 

12 ‘‘(i) expanding programs for medica13 tion-assisted treatment of prescription 

14 drug and opioid addiction, including train15 ing for treatment and recovery support 

16 providers; 

17 ‘‘(ii) developing, implementing, or ex18 panding programs for behavioral health 

19 therapy for individuals who are in treat20 ment for prescription drug and opioid ad21 diction, including contingency manage22 ment, cognitive behavioral therapy, and 

23 motivational enhancements; or 

24 ‘‘(iii) developing, implementing, or ex25 panding programs to screen individuals 

mstockstill on DSK4VPTVN1PROD with BILLS

70 

•HR 5845 IH

1 who are in treatment for prescription drug 

2 and opioid addiction for hepatitis C and 

3 HIV, and provide treatment for those indi4 viduals if clinically appropriate; and 

5 ‘‘(D) developing, implementing, and ex6 panding programs to prevent overdose death of 

7 prescription medications and opioids. 

8 ‘‘(3) PLANNING GRANT APPLICATIONS.— 

9 ‘‘(A) APPLICATION.— 

10 ‘‘(i) IN GENERAL.—A State desiring a 

11 planning grant under this section to pre12 pare a comprehensive plan for an inte13 grated opioid abuse response initiative 

14 shall submit to the Attorney General an 

15 application in such form, and containing 

16 such information, as the Attorney General 

17 may prescribe by regulation or guidelines. 

18 ‘‘(ii) REQUIREMENTS.—An application 

19 for a planning grant under this section 

20 shall, at a minimum, include— 

21 ‘‘(I) a budget and a budget jus22 tification for the activities to be car23 ried out using the grant; 

24 ‘‘(II) a description of the activi25 ties proposed to be carried out using 

mstockstill on DSK4VPTVN1PROD with BILLS

71 

•HR 5845 IH

1 the grant, including a schedule for 

2 completion of such activities; 

3 ‘‘(III) outcome measures that will 

4 be used to measure the effectiveness 

5 of the programs and initiatives to ad6 dress opioids; and 

7 ‘‘(IV) a description of the per8 sonnel necessary to complete such ac9 tivities. 

10 ‘‘(B) PERIOD; NONRENEWABILITY.—A 

11 planning grant under this section shall be for a 

12 period of 1 year. A State may not receive more 

13 than 1 planning grant under this section. 

14 ‘‘(C) AMOUNT.—A planning grant under 

15 this section may not exceed $100,000, except 

16 that the Attorney General may, for good cause, 

17 approve a grant in a higher amount. 

18 ‘‘(D) STRATEGIC PLAN AND PROGRAM IM19 PLEMENTATION PLAN.—A State receiving a 

20 planning grant under this section shall develop 

21 a strategic plan and a program implementation 

22 plan. 

23 ‘‘(4) IMPLEMENTATION GRANTS.— 

24 ‘‘(A) APPLICATION.—A State desiring an 

25 implementation grant under this section to immstockstill on DSK4VPTVN1PROD with BILLS

72 

•HR 5845 IH

1 plement a comprehensive strategy for address2 ing opioid abuse shall submit to the Attorney 

3 General an application in such form, and con4 taining such information, as the Attorney Gen5 eral may prescribe by regulation or guidelines. 

6 ‘‘(B) USE OF FUNDS.—A State that re7 ceives an implementation grant under this sec8 tion shall use the grant for the cost of carrying 

9 out an integrated opioid abuse response pro10 gram in accordance with this section, including 

11 for technical assistance, training, and adminis12 trative expenses. 

13 ‘‘(C) REQUIREMENTS.—An integrated 

14 opioid abuse response program carried out 

15 using an implementation grant under this sec16 tion shall— 

17 ‘‘(i) ensure that each prescriber of a 

18 schedule II, III, or IV controlled substance 

19 in the State— 

20 ‘‘(I) registers with the prescrip21 tion drug monitoring program of the 

22 State; and 

23 ‘‘(II) consults the prescription 

24 drug monitoring program database of 

mstockstill on DSK4VPTVN1PROD with BILLS

73 

•HR 5845 IH

1 the State before prescribing a sched2 ule II, III, or IV controlled substance; 

3 ‘‘(ii) ensure that each dispenser of a 

4 schedule II, III, or IV controlled substance 

5 in the State— 

6 ‘‘(I) registers with the prescrip7 tion drug monitoring program of the 

8 State; 

9 ‘‘(II) consults the prescription 

10 drug monitoring program database of 

11 the State before dispensing a schedule 

12 II, III, or IV controlled substance; 

13 and 

14 ‘‘(III) reports to the prescription 

15 drug monitoring program of the 

16 State, at a minimum, each instance in 

17 which a schedule II, III, or IV con18 trolled substance is dispensed, with 

19 limited exceptions, as defined by the 

20 State, which shall indicate the pre21 scriber by name and National Pro22 vider Identifier; 

23 ‘‘(iii) require that, not fewer than 4 

24 times each year, the State agency or agen25 cies that administer the prescription drug 

mstockstill on DSK4VPTVN1PROD with BILLS

74 

•HR 5845 IH

1 monitoring program of the State prepare 

2 and provide to each prescriber of a sched3 ule II, III, or IV controlled substance an 

4 informational report that shows how the 

5 prescribing patterns of the prescriber com6 pare to prescribing practices of the peers 

7 of the prescriber and expected norms; 

8 ‘‘(iv) if informational reports provided 

9 to a prescriber under clause (iii) indicate 

10 that the prescriber is repeatedly falling 

11 outside of expected norms, direct the pre12 scriber to educational resources on appro13 priate prescribing of controlled substances; 

14 ‘‘(v) ensure that the prescriber licens15 ing board of the State receives a report de16 scribing any prescribers that repeatedly 

17 fall outside of expected norms, as described 

18 in clause (iii); 

19 ‘‘(vi) require consultation with the 

20 Single State Authority for Substance 

21 Abuse; and 

22 ‘‘(vii) establish requirements for how 

23 data will be collected and analyzed to de24 termine the effectiveness of the program. 

mstockstill on DSK4VPTVN1PROD with BILLS

75 

•HR 5845 IH

1 ‘‘(D) PERIOD.—An implementation grant 

2 under this section shall be for a period of 2 

3 years. 

4 ‘‘(E) AMOUNT.—The amount of an imple5 mentation grant under this section may not ex6 ceed $5,000,000 except that the Attorney Gen7 eral may, for good cause, approve a grant in a 

8 higher amount. 

9 ‘‘(5) PRIORITY CONSIDERATIONS.—In awarding 

10 planning and implementation grants under this sec11 tion, the Attorney General shall give priority to a 

12 State that— 

13 ‘‘(A) provides civil liability protection for 

14 first responders, health professionals, and fam15 ily members administering naloxone to counter16 act opioid overdoses by— 

17 ‘‘(i) enacting legislation that provides 

18 such civil liability protection; or 

19 ‘‘(ii) providing a certification by the 

20 attorney general of the State that the at21 torney general has— 

22 ‘‘(I) reviewed any applicable civil 

23 liability protection law to determine 

24 the applicability of the law with re25 spect to first responders, health care 

mstockstill on DSK4VPTVN1PROD with BILLS

76 

•HR 5845 IH

1 professionals, family members, and 

2 other individuals who may administer 

3 naloxone to individuals reasonably be4 lieved to be suffering from opioid 

5 overdose; and 

6 ‘‘(II) concluded that the law de7 scribed in subclause (I) provides ade8 quate civil liability protection applica9 ble to such persons; 

10 ‘‘(B) have in effect legislation or imple11 ment a policy under which the State shall not 

12 terminate, but may suspend, enrollment under 

13 the State plan for medical assistance under title 

14 XIX of the Social Security Act (42 U.S.C. 1396 

15 et seq.) for an individual who is incarcerated for 

16 a period of fewer than 2 years; 

17 ‘‘(C) have a process for enrollment in serv18 ices and benefits necessary by criminal justice 

19 agencies to initiate or continue treatment in the 

20 community, under which an individual who is 

21 incarcerated may, while incarcerated, enroll in 

22 services and benefits that are necessary for the 

23 individual to continue treatment upon release 

24 from incarceration; 

mstockstill on DSK4VPTVN1PROD with BILLS

77 

•HR 5845 IH

1 ‘‘(D) ensures the capability of data sharing 

2 with other States, such as by making data 

3 available to a prescription monitoring hub; 

4 ‘‘(E) ensures that data recorded in the 

5 prescription drug monitoring program database 

6 of the State is available within 24 hours, to the 

7 extent possible; and 

8 ‘‘(F) ensures that the prescription drug 

9 monitoring program of the State notifies pre10 scribers and dispensers of schedule II, III, or 

11 IV controlled substances when overuse or mis12 use of such controlled substances by patients is 

13 suspected.’’. 

14 (c) AUTHORIZATION OF APPROPRIATIONS.—There 

15 are authorized to be appropriated to carry out this section 

16 $15,000,000 for each of fiscal years 2016 through 2020. 

17 TITLE VII—GOOD SAMARITAN 

18 PROTECTION RULE OF CON19 STRUCTION 

20 All provisions in this Act and amendments made by 

21 this Act shall contain a priority consideration for grant 

22 eligibility and awards to provide protections from civil li23 ability with respect to the emergency administration of 

24 opioid overdose drugs. 

mstockstill on DSK4VPTVN1PROD with BILLS

78 

•HR 5845 IH

1 Each grant made under this Act or an amendment 

2 made by this Act shall give priority to a State that— 

3 (A) provides civil liability protection for first re4 sponders, health professionals, and family members 

5 and bystanders, administering naloxone to counter6 act opioid overdoses by— 

7 (i) enacting legislation that provides such 

8 civil liability protection; or 

9 (ii) providing a certification by the attor10 ney general of the State that the attorney gen11 eral has— 

12 (I) reviewed any applicable civil liabil13 ity protection law to determine the applica14 bility of the law with respect to first re15 sponders, health care professionals, family 

16 members, and other individuals who may 

17 administer naloxone to individuals reason18 ably believed to be suffering from opioid 

19 overdose; and 

20 (II) concluded that the law described 

21 in subclause (I) provides adequate civil li22 ability protection applicable to such per23 sons. 

mstockstill on DSK4VPTVN1PROD with BILLS

79 

•HR 5845 IH

1 TITLE VIII—OFFSET 

2 SEC. 701. OFFSET. 

3 The amounts expended to carry out this Act shall be 

4 offset by a corresponding reduction in Federal discre5 tionary spending. 

Æ 

mstockstill on DSK4VPTVN1PROD with BILLS